Skip to main content

CORRECTION article

Front. Immunol., 13 November 2023
Sec. Inflammation
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1332633

Corrigendum: RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond

This article is a correction to:

  1. RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond

    1. Read original article
Xiaoyu Liu,Xiaoyu Liu1,2A-Ling Tang,A-Ling Tang1,3Jie Chen,Jie Chen1,2Nan Gao,Nan Gao1,2Guoqiang Zhang*Guoqiang Zhang1*Cheng Xiao*Cheng Xiao1*
  • 1Department of Emergency, China-Japan Friendship Hospital, Beijing, China
  • 2China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 3Graduate School, Beijing University of Chinese Medicine, Beijing, China

A Corrigendum on
RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond.

By Liu X, Tang A-L, Chen J, Gao N, Zhang G and Xiao C (2023) Front. Immunol. 14:1114103. doi: 10.3389/fimmu.2023.1114103

In the published article, an author name was incorrectly written as “Chen Xiao”. The correct spelling is “Cheng Xiao”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: RIPK1, sepsis, cytokine storm, inflammatory response, PANoptosis

Citation: Liu X, Tang A-L, Chen J, Gao N, Zhang G and Xiao C (2023) Corrigendum: RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond. Front. Immunol. 14:1332633. doi: 10.3389/fimmu.2023.1332633

Received: 03 November 2023; Accepted: 06 November 2023;
Published: 13 November 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Liu, Tang, Chen, Gao, Zhang and Xiao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guoqiang Zhang, zhangchong2003@vip.sina.com; Cheng Xiao, xc2002812@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.